15.03.2018 • News

CCL Buys Treofan America for $255 Million

CCL Buys Treofan America for $255 Million
CCL Buys Treofan America for $255 Million

Canadian specialty label and packaging manufacturer CCL Industries has signed a binding agreement to buy Treofan America and Trespaphan Mexico Holding from Italian private equity firm M&C.

The purchase price is $255 million, net of cash and assumed debt. The transaction, which remains subject to regulatory approvals and customary conditions, is expected to close in the second quarter.

The entities being acquired represent the Treofan Americas business, namely the production of biaxially oriented PP (BOPP) films, in Canada, the US and Latin America. M&C will continue to control the European business through Treofan Germany and Treofan Italy, which are not part of the deal.

Treofan America operates a 60,000 t/y BOPP film plant in Zacapu, Mexico, and posted sales of around $212 million in 2017, with an (estimated) adjusted EBITDA of $40 million. The company is currently installing another extrusion line at its plant, adding 30,000 t/y of capacity. CCL has agreed to reimburse M&C for all expenditure incurred on the project at closing, on top of the agreed purchase price. Total outlay on the project is estimated to be $65 million.

The deal comes just over a year after CCL bought the UK’s Innovia Films for around $839 million. “The proposed acquisition gives Innovia a solid strategic footprint for BOPP films in both North America and Europe with highly complementary technologies and products,” said CCL’s president and CEO, Geoffrey Martin.

Treofan’s CEO Walter Bickel said proceeds from the sale will be used to deleverage the company and to further develop its production sites in Europe.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.